369 related articles for article (PubMed ID: 18417177)
1. Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma.
Hesseling PB; Molyneux E; Kamiza S; Broadhead R
Trans R Soc Trop Med Hyg; 2008 Jun; 102(6):602-7. PubMed ID: 18417177
[TBL] [Abstract][Full Text] [Related]
2. The 2000 Burkitt lymphoma trial in Malawi.
Hesseling P; Broadhead R; Mansvelt E; Louw M; Wessels G; Borgstein E; Schneider J; Molyneux E
Pediatr Blood Cancer; 2005 Mar; 44(3):245-50. PubMed ID: 15547922
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
4. [Maxillofacial location of Burkitt's lymphoma in children treated at the University Hospital Center in Bamako, Mali: a 24-case series].
Togo B; Keita M; Medefo D; Traore F; Sidibe T
Med Trop (Mars); 2008 Dec; 68(6):600-2. PubMed ID: 19639827
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA
Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967
[TBL] [Abstract][Full Text] [Related]
6. Outcome is unchanged by adding vincristine upfront to the Malawi 28-day protocol for endemic Burkitt lymphoma.
Depani S; Banda K; Bailey S; Israels T; Chagaluka G; Molyneux E
Pediatr Blood Cancer; 2015 Nov; 62(11):1929-34. PubMed ID: 26052841
[TBL] [Abstract][Full Text] [Related]
7. [Long-lasting remission of Burkitt's disease in African children. Apropos of 6 cases].
Plo JK; Rain JD; Andoh J; Tea DN; Essoh NP
Med Trop (Mars); 1986; 46(2):141-6. PubMed ID: 3724411
[TBL] [Abstract][Full Text] [Related]
8. [Treatment and prognosis of children with relapsed non-Hodgkin's lymphoma--a report from CCLSG-NHL 890 Study. Children's Cancer and Leukemia Study Group (CCLSG)].
Tsurusawa M; Katano N; Asami K; Watanabe A; Koizumi S; Miyake M; Kikuta A; Iwai A; Yamamura Y; Kawano Y; Mugishima H; Sekine I; Matsushita T; Horikoshi Y; Kikuchi M; Anami K; Fujimoto T
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1695-702. PubMed ID: 11057320
[TBL] [Abstract][Full Text] [Related]
9. The Cameroon 2008 Burkitt lymphoma protocol: improved event-free survival with treatment adapted to disease stage and the response to induction therapy.
Hesseling PB; Njume E; Kouya F; Katayi T; Wharin P; Tamannai M; Achu P; Kidd M; McCormick P
Pediatr Hematol Oncol; 2012 Mar; 29(2):119-29. PubMed ID: 22376015
[TBL] [Abstract][Full Text] [Related]
10. Advanced stage (III-IV) Burkitt's lymphoma and B-cell acute lymphoblastic leukaemia in children: kinetic and pharmacologic rationale for treatment and recent results (1979-1983).
Murphy SB; Bowman WP; Hustu HO; Berard CW
IARC Sci Publ; 1985; (60):405-18. PubMed ID: 3905592
[TBL] [Abstract][Full Text] [Related]
11. High-dose cyclophosphamide and intermediate-dose methotrexate for the treatment of far-advanced Burkitt's lymphoma.
Brecher ML; Gardner RV; Ettinger LJ; Tebbi CK; Green DM; Freeman AI
Am J Pediatr Hematol Oncol; 1985; 7(2):117-24. PubMed ID: 3842557
[TBL] [Abstract][Full Text] [Related]
12. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
Schwenn MR; Blattner SR; Lynch E; Weinstein HJ
J Clin Oncol; 1991 Jan; 9(1):133-8. PubMed ID: 1985162
[TBL] [Abstract][Full Text] [Related]
13. [Non-Hodgkin's lymphomas in childhood: results of treatment in patients in stage III].
Maluf Júnior PT; Britto JL; Cristofani L; Almeida MT; Odone Filho V
Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(6):278-82. PubMed ID: 8029600
[TBL] [Abstract][Full Text] [Related]
14. Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate.
Hesseling P; Molyneux E; Kamiza S; Israels T; Broadhead R
Ann Trop Paediatr; 2009 Mar; 29(1):29-34. PubMed ID: 19222931
[TBL] [Abstract][Full Text] [Related]
15. High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults.
Di Nicola M; Carlo-Stella C; Mariotti J; Devizzi L; Massimino M; Cabras A; Magni M; Matteucci P; Guidetti A; Gandola L; Gianni AM
Br J Haematol; 2004 Sep; 126(6):815-20. PubMed ID: 15352985
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].
Madani A; Benhmiddoune L; Zafad S; Harif M; Quessar A; Benchekroun S
Bull Cancer; 2005 Feb; 92(2):193-8. PubMed ID: 15749649
[TBL] [Abstract][Full Text] [Related]
17. Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience.
Ziegler JL
N Engl J Med; 1977 Jul; 297(2):75-80. PubMed ID: 865579
[TBL] [Abstract][Full Text] [Related]
18. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
Sun XF; Zhen ZJ; Lui DG; Xia Y; He YJ; Wang ZH; Lin JY; Guan ZZ
Eur J Haematol; 2006 Nov; 77(5):365-71. PubMed ID: 16879606
[TBL] [Abstract][Full Text] [Related]
19. Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi.
Israëls T; van de Wetering MD; Hesseling P; van Geloven N; Caron HN; Molyneux EM
Pediatr Blood Cancer; 2009 Jul; 53(1):47-52. PubMed ID: 19338050
[TBL] [Abstract][Full Text] [Related]
20. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]